InfuSystem Holdings (INFU) Asset Utilization Ratio (2011 - 2026)
InfuSystem Holdings (INFU) posted Asset Utilization Ratio of 1.43 for Q1 2026, down 0.61% on a QoQ basis from 1.44 in Q4 2025, and up 8.01% year-over-year from 1.32 in Q1 2025.
InfuSystem Holdings (INFU) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
InfuSystem Holdings' Asset Utilization Ratio history runs 16 years deep, the most recent figure standing at 1.43 for Q1 2026.
- Quarterly Asset Utilization Ratio rose 8.01% year-over-year to 1.43 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1.43 (up 8.01% YoY) and the FY2025 annual result came in at 1.41, up 7.59% from the prior year.
- Asset Utilization Ratio was 1.43 for Q1 2026 at InfuSystem Holdings, down from 1.44 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 1.44 in Q4 2025 and bottomed at 1.07 in Q1 2022.
- A 5-year average of 1.24 and a median of 1.23 in 2024 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2022 — Asset Utilization Ratio slipped 0.01% — and 2025, when it rose 13.73%.
- InfuSystem Holdings' Asset Utilization Ratio stood at 1.11 in 2022, then rose by 10.75% to 1.23 in 2023, then advanced by 5.2% to 1.29 in 2024, then increased by 11.41% to 1.44 in 2025, then retreated by 0.61% to 1.43 in 2026.
- Business Quant data shows INFU's Asset Utilization Ratio at 1.43 in Q1 2026, 1.44 in Q4 2025, and 1.41 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.46 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 0.54 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 0.39 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 0.47 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 0.47 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 0.74 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 0.65 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 0.57 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | InfuSystem Holdings | 179.47 Mn | 177.37 Mn | 19.68 Mn | 1.43 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.43 |
| Dec 31, 2025 | 1.44 |
| Sep 30, 2025 | 1.41 |
| Jun 30, 2025 | 1.36 |
| Mar 31, 2025 | 1.32 |
| Dec 31, 2024 | 1.29 |
| Sep 30, 2024 | 1.24 |
| Jun 30, 2024 | 1.21 |
| Mar 31, 2024 | 1.23 |
| Dec 31, 2023 | 1.23 |
| Sep 30, 2023 | 1.20 |
| Jun 30, 2023 | 1.15 |
| Mar 31, 2023 | 1.13 |
| Dec 31, 2022 | 1.11 |
| Sep 30, 2022 | 1.09 |
| Jun 30, 2022 | 1.09 |
| Mar 31, 2022 | 1.07 |
| Dec 31, 2021 | 1.06 |
| Sep 30, 2021 | 1.05 |
| Jun 30, 2021 | 1.06 |